Treating pediatric obesity
In part 1 of our obesity series, Katherine H. Saunders, MD, DABOM, discusses methods of treating pediatric obesity, including medicines approved by the FDA and the advantages of Intellihealth.
COVID-19 vaccine effective against hospitalization from Omicron variant
In a recent study, children aged 5 to 11 years were less likely to be hospitalized with the Omicron strand if they received vaccination against COVID-19.
Penicillin allergy documentation uninformative in allergy tabs
In a recent study, penicillin allergy documentation was uninformative in allergy tabs, and children were not often referred to allergists.
Covis withdraws Makena from the market
Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.
E-cigarette use more common among sexual minority youth
In a recent study, the prevalence of e-cigarette use was greater among sexual minority youth than heterosexual or questioning youth.
Poor rate of outpatient care following mental health ED visit
In a recent study, a poor connection was reported between mental health emergency department discharge and follow-ups through outpatient care.
FDA accepts sNDA for empagliflozin in children with type 2 diabetes
A supplemental New Drug Application for empagliflozin (Jardiance; Boehringer Ingelheim and Eli Lilly and Company) in pediatric patients with type 2 diabetes has been accepted by the FDA.
The development of pediatric cardiovascular care
Anne Dubin, MD, division chief of pediatric cardiology at Stanford Medicine Children's Health, discusses developments made in pediatric cardiovascular care in recent decades, along with developments she hopes to see in the future.
Childhood respiratory infection linked to adult mortality
In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.
FDA accepts NDA for berdazimer gel to treat molluscum contagiosum
Following positive results from a phase 3 clinical trial, the FDA has accepted a New Drug Application for berdazimer gel, 10.3% (Novan) for treating patients with molluscum contagiosum.
Dupilumab sNDA accepted for chronic spontaneous urticaria in adolescents
A supplemental Biologics License Application has been accepted by the FDA for treating adolescents and adults with chronic spontaneous urticaria.
AAP: Reducing crowding in emergency departments
In a new policy statement, the American Academy of Pediatrics has provided guidelines on reducing crowding in emergency departments.
Violence encounters increase suicidal ideation among adolescents
In a recent study, the rate of suicidal ideation was 1.7 times greater among adolescents with depression who had experienced a violent encounter in the past year.
Associations of preterm birth and postnatal growth with brain maturation
In a recent study, worse neurodevelopmental outcomes were seen in children born preterm and with postnatal growth failure.
FDA approves velmanase alfa-tycv for alpha-mannosidosis
Velmanase alfa-tycv (Lamzede, Chiesi Global Rare Diseases) has received approval by the FDA for treating alpha-mannosidosis in adult and pediatric patients.
FDA approves omaveloxolone for pediatric use
Omaveloxolone (SKYCLARYS, Reata Pharmaceuticals) has received FDA approval for treating Friedreich’s ataxia in patients aged 16 years and older.
Effectiveness of monovalent mRNA vaccines against COVID-19 in young children
In a recent report from the CDC, monovalent vaccines from Moderna and Pfizer have shown vaccine effectiveness in children aged 3 to 5 years in at least the first 4 months after vaccination.
FDA accepts application for VP-102 for treating molluscum contagiosum
A new drug application for VP-102 for treating molluscum contagiosum has been accepted by the FDA.
Suicide rates among youths during COVID-19
In a recent study, rates of suicide during the COVID-19 pandemic were higher among youths aged 5 to 24 years than expected based on trends prior to the pandemic.
Ultrasound radiomics for predicting extrathyroidal extension in children
In a recent study, ultrasound radiomics showed effective predictive ability for extrathyroidal extension (ETE) in pediatric papillary thyroid cancer (PTC).
Sadness and violence among teenage girls
A recent report from the CDC detailed increasing rates of sadness and violence among US teenage girls.
Fruit, vegetable, and sugary drink consumption in young children
A recent report from the Centers for Disease Control and Prevention outlined rates of fruit, vegetable, and sugary drink intake among young children by state.
How parents manage fever in children
A recent poll from the C.S. Mott Children’s Hospital National Poll on Children’s Health showed how parents respond to potential fever in their children.
Changes in food insecurity for families with children
In a recent study, higher rates of food insecurity were found among low-income families with children in the United States.
Vitamin D supplementation not associated with bone mass in infants
In a recent study, the effects on bone mass did not differ between groups of infants with different levels of vitamin D supplementation.
Barriers to produce intake
While many caregivers want to increase their child’s fruit and vegetable intake, barriers keep them from receiving fresh produce.
Window of susceptibility for recurrent acute otitis media
A recent study examined the window of susceptibility for recurrent acute otitis media in young children, along with developing predictive models and determining the frequency of tympanostomy tubes use.
Effects of COVID-19 on maternal and neonatal outcomes
In a recent analysis, worse maternal and neonatal outcomes were found when mothers were infected with COVID-19 close to delivery.
Methods for increasing adolescent epinephrine auto-injector carrying
In a recent study, the use of text messages alongside financial incentives increased epinephrine auto-injector carrying among adolescents.
FDA grants priority review for linaclotide in pediatric patients
Linaclotide (LINZESS; Ironwood Pharmaceuticals) has been granted Priority Review by the US Food and Drug Administration for treating pediatric patients with functional constipation.
2 Clarke Drive Cranbury, NJ 08512